Photothermal therapy: a novel potential treatment for prostate cancer

Dong, Zirui; Xue, Kaming; Verma, Anushikha; Shi, Jian; Wei, Zhihao; Xia, Xiaotian; Wang, Keshan; Zhang, Xiaoping

doi:10.1039/d4bm00057a

Biomater. Sci.

2024

DOI: 10.1039/d4bm00057a

|View full text |Cite

Photothermal therapy: a novel potential treatment for prostate cancer

Zirui Dong,

Kaming Xue,

Anushikha Verma

et al.

Abstract: This review discussed photothermal therapy from basic information to its circumstances and potential in protate cancer treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 224 publications

(205 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients

Pietrzak,

Marciniak,

Derkacz

et al. 2024

Cancers

View full text Add to dashboard Cite

Prostate cancer is the most common cancer diagnosed in men and the second leading cause of death in male cancer patients. The WHO suggests that cobalt is involved in the carcinogenesis of prostate cancer. There are, however, no studies associating cobalt levels and prostate cancer patient survival. In this study, 261 Polish prostate cancer (n = 261) patients were recruited into a prospective cohort between 2009 and 2015. Serum cobalt levels were measured using ICP-MS after prostate cancer diagnosis and before treatment. All study participants were assigned into quartiles (QI-QIV) based on the distribution of serum cobalt levels among censored patients. Univariable and multivariable COX regression models were used to calculate hazard ratios (HRs) for each serum cobalt level quartile. We found a significant relationship between high serum cobalt levels and poor prostate cancer patient total survival (HR = 2.60; 95% CI: 1.17–5.82; p = 0.02). In relation to prostate cancer patients who died as a result of other non-cancer causes, the association with high levels of cobalt was even stronger (HR = 3.67; 95% CI: 1.03–13.00; p = 0.04). The impact of high serum cobalt levels on overall survival of prostate cancer-specific-related deaths was not statistically significant.

show abstract

Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients

Pietrzak,

Marciniak,

Derkacz

et al. 2024

Cancers

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Photothermal therapy: a novel potential treatment for prostate cancer

Abstract: This review discussed photothermal therapy from basic information to its circumstances and potential in protate cancer treatment.

Cited by 1 publication

References 224 publications

Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients

Cobalt Serum Level as a Biomarker of Cause-Specific Survival among Prostate Cancer Patients

Contact Info

Product

Resources

About